| Preoperative variables . | Univariable . | Multivariable . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Age | 1.11 (1.05–1.18) | <0.001 | 1.11 (1.03–1.19) | 0.004 |
| Previous alcoholization | 5.41 (2.20–13.36) | <0.001 | 2.93 (1.04–8.31) | 0.042 |
| NYHA III–IV | 0.70 (0.18–2.74) | 0.60 | ||
| Preoperative AF | 3.15 (0.59–16.65) | 0.13 | ||
| LVEF | 0.90 (0.79–1.03) | 0.28 | ||
| SPAP | 0.90 (0.84–1.01) | 0.10 | ||
| Septal thickness | 1.17 (0.62–2.23) | 0.63 | ||
| LVOT gradient | 1.01 (0.99–1.04) | 0.35 | ||
| MR ≥3+/4+ | 2.95 (0.64–13.67) | 0.168 | 3.93 (0.93–16.68) | 0.093 |
| MV surgery ± myectomy | 3.21 (0.87–11.81) | 0.070 | 1.13 (0.28–4.64) | 0.196 |
| Preoperative variables . | Univariable . | Multivariable . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Age | 1.11 (1.05–1.18) | <0.001 | 1.11 (1.03–1.19) | 0.004 |
| Previous alcoholization | 5.41 (2.20–13.36) | <0.001 | 2.93 (1.04–8.31) | 0.042 |
| NYHA III–IV | 0.70 (0.18–2.74) | 0.60 | ||
| Preoperative AF | 3.15 (0.59–16.65) | 0.13 | ||
| LVEF | 0.90 (0.79–1.03) | 0.28 | ||
| SPAP | 0.90 (0.84–1.01) | 0.10 | ||
| Septal thickness | 1.17 (0.62–2.23) | 0.63 | ||
| LVOT gradient | 1.01 (0.99–1.04) | 0.35 | ||
| MR ≥3+/4+ | 2.95 (0.64–13.67) | 0.168 | 3.93 (0.93–16.68) | 0.093 |
| MV surgery ± myectomy | 3.21 (0.87–11.81) | 0.070 | 1.13 (0.28–4.64) | 0.196 |
AF: atrial fibrillation; LVEF: left ventricular ejection fraction; LVOT: left ventricle outflow tract; MR: mitral regurgitation; MV: mitral valve; NYHA: New York Heart Association; SPAP: systolic pulmonary artery pressure.
| Preoperative variables . | Univariable . | Multivariable . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Age | 1.11 (1.05–1.18) | <0.001 | 1.11 (1.03–1.19) | 0.004 |
| Previous alcoholization | 5.41 (2.20–13.36) | <0.001 | 2.93 (1.04–8.31) | 0.042 |
| NYHA III–IV | 0.70 (0.18–2.74) | 0.60 | ||
| Preoperative AF | 3.15 (0.59–16.65) | 0.13 | ||
| LVEF | 0.90 (0.79–1.03) | 0.28 | ||
| SPAP | 0.90 (0.84–1.01) | 0.10 | ||
| Septal thickness | 1.17 (0.62–2.23) | 0.63 | ||
| LVOT gradient | 1.01 (0.99–1.04) | 0.35 | ||
| MR ≥3+/4+ | 2.95 (0.64–13.67) | 0.168 | 3.93 (0.93–16.68) | 0.093 |
| MV surgery ± myectomy | 3.21 (0.87–11.81) | 0.070 | 1.13 (0.28–4.64) | 0.196 |
| Preoperative variables . | Univariable . | Multivariable . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Age | 1.11 (1.05–1.18) | <0.001 | 1.11 (1.03–1.19) | 0.004 |
| Previous alcoholization | 5.41 (2.20–13.36) | <0.001 | 2.93 (1.04–8.31) | 0.042 |
| NYHA III–IV | 0.70 (0.18–2.74) | 0.60 | ||
| Preoperative AF | 3.15 (0.59–16.65) | 0.13 | ||
| LVEF | 0.90 (0.79–1.03) | 0.28 | ||
| SPAP | 0.90 (0.84–1.01) | 0.10 | ||
| Septal thickness | 1.17 (0.62–2.23) | 0.63 | ||
| LVOT gradient | 1.01 (0.99–1.04) | 0.35 | ||
| MR ≥3+/4+ | 2.95 (0.64–13.67) | 0.168 | 3.93 (0.93–16.68) | 0.093 |
| MV surgery ± myectomy | 3.21 (0.87–11.81) | 0.070 | 1.13 (0.28–4.64) | 0.196 |
AF: atrial fibrillation; LVEF: left ventricular ejection fraction; LVOT: left ventricle outflow tract; MR: mitral regurgitation; MV: mitral valve; NYHA: New York Heart Association; SPAP: systolic pulmonary artery pressure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
